Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark E Sherman

Showing results (61-70 of 343) with videos related to

Pageof 35
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|April 7, 2025
Cancer Incidence and Survival After Emergency Department Care in the U.S. Midwest: An Opportunity for Cancer InterceptionMark E Sherman, Michael G Heckman, Christopher C DeStephano, et al.
JAMA|July 16, 2002
Menopausal hormone replacement therapy and risk of ovarian cancerJames V Lacey, Pamela J Mink, Jay H Lubin, et al.
Cancer Causes & Control : CCC|September 29, 2009
Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot studyLisa Mirabello, Montserrat Garcia-Closas, Richard Cawthon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal womenCatherine Schairer, Deirdre Hill, Susan R Sturgeon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2008
Measurement of sex steroid hormones in breast adipocytes: methods and implicationsRoni T Falk, Elisabet Gentzschein, Frank Z Stanczyk, et al.
Scientific Reports|July 4, 2025
Mechanisms of osteopontin-stabilized amorphous calcium phosphate calcification in benign and pre-malignant breast diseaseMayandi Sivaguru, Sarah E Schrup, Kyle W Fouke, et al.
Breast Cancer Research and Treatment|January 5, 2021
Breast cancer risk factors by mode of detection among screened women in the Cancer Prevention Study-IIMia M Gaudet, Emily Deubler, W Ryan Diver, et al.
Gynecologic Oncology|November 10, 2021
The cost of diagnosing endometrial cancer: Quantifying the healthcare cost of an abnormal uterine bleeding workupSimrit K Warring, Bijan Borah, James Moriarty, et al.
Plos One|August 26, 2016
Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer PatientsMark E Sherman, Laura Ichikawa, Ruth M Pfeiffer, et al.
Menopause (New York, N.Y.)|November 21, 2013
Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different agesGretchen L Gierach, Ruth M Pfeiffer, Deesha A Patel, et al.
Pageof 35

Showing results (61-70 of 343) with videos related to

Sort By:
Pageof 35
Cancer Prevention Research (Philadelphia, Pa.)|April 7, 2025
Cancer Incidence and Survival After Emergency Department Care in the U.S. Midwest: An Opportunity for Cancer InterceptionMark E Sherman, Michael G Heckman, Christopher C DeStephano, et al.
JAMA|July 16, 2002
Menopausal hormone replacement therapy and risk of ovarian cancerJames V Lacey, Pamela J Mink, Jay H Lubin, et al.
Cancer Causes & Control : CCC|September 29, 2009
Leukocyte telomere length in a population-based case-control study of ovarian cancer: a pilot studyLisa Mirabello, Montserrat Garcia-Closas, Richard Cawthon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal womenCatherine Schairer, Deirdre Hill, Susan R Sturgeon, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2008
Measurement of sex steroid hormones in breast adipocytes: methods and implicationsRoni T Falk, Elisabet Gentzschein, Frank Z Stanczyk, et al.
Scientific Reports|July 4, 2025
Mechanisms of osteopontin-stabilized amorphous calcium phosphate calcification in benign and pre-malignant breast diseaseMayandi Sivaguru, Sarah E Schrup, Kyle W Fouke, et al.
Breast Cancer Research and Treatment|January 5, 2021
Breast cancer risk factors by mode of detection among screened women in the Cancer Prevention Study-IIMia M Gaudet, Emily Deubler, W Ryan Diver, et al.
Gynecologic Oncology|November 10, 2021
The cost of diagnosing endometrial cancer: Quantifying the healthcare cost of an abnormal uterine bleeding workupSimrit K Warring, Bijan Borah, James Moriarty, et al.
Plos One|August 26, 2016
Relationship of Predicted Risk of Developing Invasive Breast Cancer, as Assessed with Three Models, and Breast Cancer Mortality among Breast Cancer PatientsMark E Sherman, Laura Ichikawa, Ruth M Pfeiffer, et al.
Menopause (New York, N.Y.)|November 21, 2013
Long-term overall and disease-specific mortality associated with benign gynecologic surgery performed at different agesGretchen L Gierach, Ruth M Pfeiffer, Deesha A Patel, et al.
Pageof 35